Search

Search Results

• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1302

  PDF: 968

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  https://doi.org/10.4081/reumatismo.2006.116

  1214

  PDF: 1198

• “THE LEEDS IDEA”: AN HISTORICAL ACCOUNT OF THE SPONDARTHRITIS CONCEPT

  J.M.H. Moll

  13-18

  https://doi.org/10.4081/reumatismo.2007.1s.13

  809

  PDF: 782

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1036

  PDF: 1003

• IL-1Ra: its role in rheumatoid arthritis

  M. Cutolo

  41-45

  https://doi.org/10.4081/reumatismo.2004.1s.41

  1481

  PDF: 2322

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  https://doi.org/10.4081/reumatismo.2010.12

  1514

  PDF: 1231

• Rheumatoid arthritis and atherosclerosis

  B. Seriolo, A. Sulli, B. Burroni, M. Cutolo

  140-146

  https://doi.org/10.4081/reumatismo.2003.140

  1847

  PDF: 2945

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1352

  PDF: 1063

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  https://doi.org/10.4081/reumatismo.2004.1s.87

  1305

  PDF: 3395
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1587

  PDF: 1114

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  1783

  PDF: 1939

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  https://doi.org/10.4081/reumatismo.2004.118

  1047

  PDF: 5838
• 

  A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis

  M. Bellan, M. Pirisi, G. Bellomo, P.P. Sainaghi

  40-42

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.941

  1332

  PDF: 745

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  https://doi.org/10.4081/reumatismo.2009.197

  1183

  PDF: 914

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1507

  PDF: 976

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.154

  2065

  PDF: 1458

• Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

  D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1658

  862

  PDF: 246
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  1567

  PDF: 754
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2346

  PDF: 1600

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  https://doi.org/10.4081/reumatismo.2008.242

  1753

  PDF: 1987

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  995

  PDF: 2947

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1096

  PDF: 745
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2268

  PDF: 1587

• How to prescribe physical exercise in rheumatology

  S. Maddali Bongi, A. Del Rosso

  4-11

  https://doi.org/10.4081/reumatismo.2010.4

  4152

  PDF: 3048

• Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes

  M. Fabris, L. Quartuccio, V. De Re, G. Pozzato, C. Mazzaro, A. Tavoni, C. Ferri, S. Salvin, A. Lerussi, C. Fabro, S. Bombardieri, S. De Vita

  28-34

  https://doi.org/10.4081/reumatismo.2008.28

  1499

  PDF: 640

• Association between Serum Amiloid A (SAA) in salivary glands and high levels of circulating β2-microglobulin in patients with Sjögren syndrome

  M. Benucci, F. Li Gobbi, A. Del Rosso, G. Gambacorta, A. Mannoni

  98-101

  https://doi.org/10.4081/reumatismo.2003.98

  993

  PDF: 1033
• 

  Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai

  P. Falsetti, E. Conticini, C. Baldi, C. Acciai, R. D'Alessandro, M. Bardelli, L. Cantarini, B. Frediani

  182-183

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1282

  728

  PDF: 637

• Farmacoeconomic impact of anti-TNFα

  G. Leardini, C. Bernardi, E. Vaccaro

  80-86

  https://doi.org/10.4081/reumatismo.2004.1s.80

  852

  PDF: 658

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  https://doi.org/10.4081/reumatismo.2010.259

  1896

  PDF: 2118

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  https://doi.org/10.4081/reumatismo.2008.95

  2568

  PDF: 1808

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  903

  PDF: 2747

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  903

  PDF: 2685

• Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist

  M.A. Cimmino

  239-241

  https://doi.org/10.4081/reumatismo.2008.239

  1015

  PDF: 678

• Are there any positive effects of TNF-alpha blockers on bone metabolism?

  B. Seriolo, S. Paolino, A. Sulli, M. Cutolo

  199-205

  https://doi.org/10.4081/reumatismo.2006.199

  1252

  PDF: 1165

• Septic arthritis: what is the role for the rheumatologist?

  F. Schiavon, M. Favero, V. Carraro, L. Riato

  1-5

  https://doi.org/10.4081/reumatismo.2008.1

  1228

  PDF: 1481
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1640

  PDF: 1015

• Magnetic resonance imaging of the peripheral joints in psoriatic arthritis

  M.C. D'Auria, R. Scarpa, M. Parodi, E. Silvestri, G. Garlaschi, M.A. Cimmino

  6-14

  https://doi.org/10.4081/reumatismo.2007.6

  1292

  PDF: 986

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2088

  PDF: 841

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  https://doi.org/10.4081/reumatismo.2005.109

  1021

  PDF: 3807

• A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome

  P. Fadda, L. La Civita, A.L. Zignego, C. Ferri

  316-323

  https://doi.org/10.4081/reumatismo.2002.316

  1208

  PDF: 2523
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1222

  1898

  PDF: 862

• CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

  N.J. Mchugh, E.R. Soriano

  81-84

  https://doi.org/10.4081/reumatismo.2007.1s.81

  786

  PDF: 776

• Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis

  R. Scrivo, A. Spadaro, V. Riccieri, M. Bombardieri, M. Di Franco, D. Celestino, G. Valesini

  250-255

  https://doi.org/10.4081/reumatismo.2005.250

  1016

  PDF: 701

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  https://doi.org/10.4081/reumatismo.2003.52

  1087

  PDF: 4789

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  https://doi.org/10.4081/reumatismo.2009.1

  1514

  PDF: 719
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1557

  2078

  PDF: 612

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  https://doi.org/10.4081/reumatismo.2010.159

  2131

  PDF: 8987

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  876

  PDF: 2016

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  https://doi.org/10.4081/reumatismo.2007.66

  1643

  PDF: 1067

• Sonographic findings of the synovial fluid

  A. Farina, E. Filippucci, W. Grassi

  261-265

  https://doi.org/10.4081/reumatismo.2002.261

  1178

  PDF: 1625